Clinical Trials Browser

Phase 2 × Antibodies, Bispecific × Clear all

NCT00467506 2011-11-11

RIT in MTC

Phase 2 Completed

Thyroid Neoplasms

NCT00149019 2011-04-08

Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

Phase 2 Withdrawn

Other solid neoplasm

Metastatic Solid Tumors